- Recommendation ID
- NICE recommended that clinical data, including genotype and sustained virological response at 12 weeks, is collected for all people treated with sofosbuvir in the NHS.
- Any explanatory notes
- NICE heard from the NHS commissioning expert that NHS England is intending to collect clinical data from people treated with the new generation of HCV treatments. NICE agreed that such efforts should be supported so that clinical data collected in routine clinical practice can be used in any review of guidance on these treatments.
Source guidance details
- Comes from guidance
- Sofosbuvir for treating chronic hepatitis C
- Date issued
- February 2015
|Is this a recommendation for the use of a technology only in the context of research?||No|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|